By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

The process of isolating plasmid DNA is important for research, gene therapy, and vaccine development. The growing demand for gene therapy and mRNA vaccines is driving the need for highly purified ...

The Cambridge Index fell 338.31 points or 1.3% to close at 26,348.5, as five out of the top ten index heavyweights posted weekly losses in their share price. Raspberry PI Holdings, down 1.8%, ...

Demonstrated feasibility of effective DNA delivery with Company's xPhore nanoparticle technologyDNA delivery technology to be offered as GenePhore to biotech / pharma companiesAddressing large and gro ...

Chemists at the National University of Singapore (NUS) have found a new use for deoxyribonucleic acid (DNA), not just as ...

Altamira will start offering its xPhore ™ platform for DNA delivery under the specific GenePhore ™ label, complementing its offerings for short RNA (OligoPhore ™), linear mRNA (SemaPhore ™) and ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

The start of the trial marks an expansion of the firm's oncology pipeline, and the firm hopes mRNA-2808 will be the first of many T-cell engagers in its portfolio.